TipRanks
Go Ultimate55% OFF

GT Biopharma (OXI) Cash flow

GT Biopharma Cash Flow

DE:OXI's free cash flow for Q2 2026 was $-4.26M. For the 2026 fiscal year, DE:OXI's free cash flow was increased by $0.00 and operating cash flow was $-4.26M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -12.91M$ -12.90M$ -8.85M$ -15.22M$ -15.61M
$ 0.00$ 12.89M$ -2.01M$ 12.14M$ -23.04M
$ 15.78M$ 2.98M$ 6.27M$ -224.00K$ 42.32M
$ 6.91M$ 4.04M$ 1.08M$ 5.67M$ 8.97M
$ -12.91M$ -12.90M$ -8.85M$ -15.22M$ -15.61M

Currency in USD

GT Biopharma Cash Flow

-40M-20M020M40M60M201720182019202020212022202320242025OperatingInvestingFinancing